Biolexis Therapeutics Inc., 2026-06-03
An SEC Form D private-offering notice from Lehi, UT, a $12,000,000 filer-stated offering target in Biotech. Filed 2026-06-03. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical-stage biotech developing oral small molecule GLP-1 and AMPK therapies for metabolic and muscle wasting diseases.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Trinsic Technologies, Inc., 2026-06-16, $3M, West Jordan, UT
- Goldenrod Therapeutics, Inc., 2026-06-03, $6.5M, Houston, TX
- Battr AI, Inc., 2026-06-09, $50K, Woods Cross, UT
- Human Biotech, Inc., 2026-06-03, $10M, Cambridge, MA
- jfish, Inc., 2026-06-05, $650K, Salt Lake City, UT
- iQure Pharma Inc., 2026-06-03, $4M, Skillman, NJ
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.